Lisata Therapeutics Announces Research License with Catalent


Catalent to evaluate certepetide with its SMARTag® antibody-drug conjugate platform Catalent to evaluate certepetide with its SMARTag® antibody-drug conjugate platform

Follow this link:
Lisata Therapeutics Announces Research License with Catalent

Related Posts